Metabolic and genetic profiling of clinical O157 and non-O157 Shiga-toxin-producing Escherichia coli.

A collection of clinical Shiga-toxin-producing Escherichia coli (STEC) strains, mainly belonging to serotypes O26, O103, O111, O145 and O157, was characterised by a polyphasic approach including molecular serotyping, PCR-based detection of virulence factors (stx1, stx2, eae, EHEC-hlyA, saa, katP, espP), carbohydrate fermentation profiles using API50 tests and random amplification of polymorphic DNA (RAPD) fingerprinting. An RAPD protocol based on the combination of 2 primers resulted in sufficiently complex patterns enabling discrimination to the serotype level. Moreover, carbohydrate fermentation profiles obtained after evaluating up to 50 different carbohydrates led to separation of different STEC serotypes. Virulence typing results confirm the association of Shiga toxins and intimin subtypes with specific serotypes and clinical diagnosis. Clinical diagnosis of strains did not correlate with either RAPD profiles or carbohydrate fermentation patterns.

[1]  M. Louie,et al.  Application of Multiplex PCR for Detection of Non-O157 Verocytotoxin-Producing Escherichia coli in Bloody Stools: Identification of Serogroups O26 and O111 , 1998, Journal of Clinical Microbiology.

[2]  J. Osek.  Development of a multiplex PCR approach for the identification of Shiga toxin‐producing Escherichia coli strains and their major virulence factor genes , 2003, Journal of applied microbiology.

[3]  W. Yam,et al.  The prevalence and characterization of verotoxin-producing Escherichia coli isolated from cattle and pigs in an abattoir in Hong Kong , 2001, Epidemiology and Infection.

[4]  L. Beutin,et al.  Characteristics and association with disease of two major subclones of Shiga toxin (Verocytotoxin)-producing strains of Escherichia coli (STEC) O157 that are present among isolates from patients in Germany. , 2002, Diagnostic microbiology and infectious disease.

[5]  R. Tauxe,et al.  The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. , 1991, Epidemiologic reviews.

[6]  P. Reeves,et al.  Structural and Genetic Characterization of Enterohemorrhagic Escherichia coli O145 O Antigen and Development of an O145 Serogroup-Specific PCR Assay , 2005, Journal of bacteriology.

[7]  James C. Paton,et al.  Detection and Characterization of Shiga ToxigenicEscherichia coli by Using Multiplex PCR Assays forstx1, stx2,eaeA, Enterohemorrhagic E. coli hlyA,rfbO111, andrfbO157 , 1998, Journal of Clinical Microbiology.

[8]  S. Tyler,et al.  Factors affecting reliability and reproducibility of amplification-based DNA fingerprinting of representative bacterial pathogens , 1997, Journal of clinical microbiology.

[9]  L. Durso,et al.  Measurements of Fitness and Competition in Commensal Escherichia coli and E. coli O157:H7 Strains , 2004, Applied and Environmental Microbiology.

[10]  L. Herman,et al.  Detection and characterization of verotoxigenic Escherichia coli by a VTEC/EHEC multiplex PCR in porcine faeces and pig carcass swabs. , 2003, Research in microbiology.

[11]  M. Micheli,et al.  Randomly amplified polymorphic DNA fingerprinting using combinations of oligonucleotide primers. , 1993, BioTechniques.

[12]  A. Vantarakis,et al.  Differentiation of faecal Escherichia coli from human and animal sources by random amplified polymorphic DNA-PCR (RAPD-PCR). , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.

[13]  J. Blanco,et al.  Serotypes, Virulence Genes, and Intimin Types of Shiga Toxin (Verotoxin)-Producing Escherichia coli Isolates from Human Patients: Prevalence in Lugo, Spain, from 1992 through 1999 , 2004, Journal of Clinical Microbiology.

[14]  G. Daube,et al.  Verotoxigenic Escherichia coli from animals, humans and foods: who's who? , 2005, Journal of applied microbiology.

[15]  W. Wade,et al.  CYTOTOXIC ENTEROPATHOGENIC ESCHERICHIA COLI , 1979, The Lancet.

[16]  S. O'Brien,et al.  Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995-1998. , 2001, Journal of medical microbiology.

[17]  Kim Ziebell,et al.  Association of Enterohemorrhagic Escherichia coliHemolysin with Serotypes of Shiga-Like-Toxin-ProducingEscherichia coli of Human and Bovine Origins , 1998, Applied and Environmental Microbiology.

[18]  S. McLellan,et al.  Genetic Characterization of Escherichia coli Populations from Host Sources of Fecal Pollution by Using DNA Fingerprinting , 2003, Applied and Environmental Microbiology.

[19]  A. Caprioli,et al.  Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. , 2005, Veterinary research.

[20]  M. McClelland,et al.  RNA fingerprinting by arbitrarily primed PCR. , 1994, PCR methods and applications.

[21]  L. Beutin,et al.  Characterization of Shiga Toxin-Producing Escherichia coli Strains Isolated from Human Patients in Germany over a 3-Year Period , 2004, Journal of Clinical Microbiology.

[22]  S. Kresovich,et al.  DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. , 1992, Nucleic acids research.

[23]  P. Srimanote,et al.  Characterization of Saa, a Novel Autoagglutinating Adhesin Produced by Locus of Enterocyte Effacement-Negative Shiga-ToxigenicEscherichia coli Strains That Are Virulent for Humans , 2001, Infection and Immunity.

[24]  A. Edefonti,et al.  Shiga Toxin–Producing Escherichia coli Infections Associated with Hemolytic Uremic Syndrome, Italy, 1988–2000 , 2003, Emerging infectious diseases.

[25]  J. Lanser,et al.  Molecular Characterization of a Shiga ToxigenicEscherichia coli O113:H21 Strain Lacking eaeResponsible for a Cluster of Cases of Hemolytic-Uremic Syndrome , 1999, Journal of Clinical Microbiology.

[26]  James C. Paton,et al.  Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections , 1998, Clinical Microbiology Reviews.

[27]  H. Karch,et al.  Molecular Characteristics and Epidemiological Significance of Shiga Toxin-Producing Escherichia coliO26 Strains , 2000, Journal of Clinical Microbiology.

[28]  S. McEwen,et al.  Associations between Virulence Factors of Shiga Toxin-ProducingEscherichia coli and Disease in Humans , 1999, Journal of Clinical Microbiology.

[29]  M. Thomashow,et al.  Introduction of pAM beta 1 into Listeria monocytogenes by conjugation and homology between native L. monocytogenes plasmids , 1984, Infection and immunity.

[30]  S. Oliver,et al.  Physiologic and molecular markers for detection of shiga toxin-producing Escherichia coli serotype O26 strains. , 2006, Foodborne pathogens and disease.

[31]  P. Fratamico,et al.  DNA sequence of the Escherichia coli O103 O antigen gene cluster and detection of enterohemorrhagic E. coli O103 by PCR amplification of the wzx and wzy genes. , 2005, Canadian journal of microbiology.

[32]  M. Karmali,et al.  Infection by verocytotoxin-producing Escherichia coli , 1989, Clinical Microbiology Reviews.

[33]  E. Nielsen,et al.  Detection and Characterization of Verocytotoxin-Producing Escherichia coli by Automated 5′ Nuclease PCR Assay , 2003, Journal of Clinical Microbiology.